NM  Vol.4 No.1 , March 2013
Seasonal, Age & Gender Variation of Guillain Barre Syndrome in a Tertiary Referral Center in India
Abstract: Background: Seasonal variation & gender preponderance have not been adequately studied in Guillain Barre Syndrome (GBS). University of Health Sciences, Rohtak is the tertiary referral facility for a large part of North West India. We conducted a prospective study to investigate differences in GBS incidence between males and females & across different seasons of the year. Methods:65 clinically diagnosed GBS patients, aged 5 - 70 years, referred for nerve conduction, Fwave & EMG studies for 3 years. Results: 64.61% were males while 35.38% were females. Maximum patients were in the age group 5 - 20 years (46.15%). The highest incidence of GBS (41.53%) were seen in the summer months; 19 (29.23%) in the spring season, 11 (16.92%) in winter season and 8 (12.30%) in rainy season. 5 patients had diarrhoea while 12 patients had flu like syndrome 1 - 2 weeks before the onset of GBS. Conclusion: The peak seasonal clustering noted by us in the summer months was consistent significantly with other Asian studies. The age and sex distribution of GBS in our series, which showed children & minor preponderance with peak incidence in 5 - 20 years age followed by another in the age group 21 - 40 years, is different from most studies which report a second peak after 50 years of age.
Cite this paper: Sharma, G. , Sood, S. and Sharma, S. (2013) Seasonal, Age & Gender Variation of Guillain Barre Syndrome in a Tertiary Referral Center in India. Neuroscience and Medicine, 4, 23-28. doi: 10.4236/nm.2013.41004.

[1]   S. L. Hauser and A. K. Asbury, “Guillain-Barre Syndrome & Other Immune-Mediated Neuropathies,” In: 16th Edition, Harrison’s Principles of Internal Medicine, McGraw Hill, 2009, pp. 2667-2671.

[2]   A. A. Amato, “Guillain Barre Syndrome & Related Disorders,” Revista Mexicana de Neurociencia, Vol. 6, No. 5, 2005, pp. 455-469.

[3]   P. H. Gordon and A. J. Wilbourn, “Early Electrodiagnostic Findings in Guillain Barre Syndrome,” Archives of Neurology, Vol. 58, No. 6, 2001, pp. 913-917.

[4]   A. McGrogan, G. C. Madle, H. E. Seaman and C. S. de Vries, “The Epidemiology of Guillain-Barré Syndrome Worldwide—A Systematic Literature Review,” Neuroepidemiology, Vol. 32, No. 2, 2009, pp. 150-163. doi:10.1159/000184748

[5]   M. Zaheer, M. Naeem and M. Nasrullah, “Seasonal Variation and Sex Distribution in Patients with Guillain-Barre Syndrome,” Pakistan Journal of Neurological Sciences, Vol. 3, No. 1, 2008, pp. 6-8.

[6]   A. Sharma, V. Lal, M. Modi, C. Vaishnavi and S. Prabhakar, “Campylobacter jejuni Infection in Guillain-Barré Syndrome: A Prospective Case Control Study in a Tertiary Care Hospital,” Neurology India, Vol. 59, No. 5, 2011, pp. 717-721. doi:10.4103/0028-3886.86547

[7]   M. A. Kannan, R. Kishore, S. A. Jabeen, K. R. Mridula, P. Rao and R. Borgohain, “Clinical, Electrophysiological Subtypes and Antiganglioside Antibodies in Childhood Guillain-Barré Syndrome,” Neurology India, Vol. 59, No. 5, 2011, pp. 727-732. doi:10.4103/0028-3886.86549

[8]   J. Meustec, F. G. A. Van Der Meche and the Dutch Guillain Barre Study Group, “Electrodiagnostic Criteria for Polyneuropathy and Demyelination: Application in 135 Patients with Guillain Barre Syndrome,” Journal of Neurology, Neurosurgery & Psychiatry, Vol. 59, No. 5, 1995, pp. 482-486. doi:10.1136/jnnp.59.5.482

[9]   S. Akbayram, M. Dogan, C. Akgün, E. Peker, R. Sayin and F. Aktar, “Clinical Features and Prognosis with Guillain-Barré Syndrome,” Annals of Indian Academy of Neurology, Vol. 14, No. 2, 2011, pp. 98-102. doi:10.4103/0972-2327.82793

[10]   R. A. Hughes and J. H. Rees, “Clinical and Epidemiological Features of Guillain Barre Syndrome,” The Journal of Infectious Diseases, Vol. 176, No. 2, 1997, pp. S92S98. doi:10.1086/513793

[11]   T. W. Ho, B. Mishu, C. Y. Li, C. Y. Gao, D. R. Cornblath, J. W. Griffin, A. K. Asbury, M. J. Blaser and G. M. McKhann, “Guillain-Barré Syndrome in Northern China. Relationship to Campylobacter jejuni Infection and AntiGlycolipid Antibodies,” Brain, Vol. 118, No. 3, 1995, pp. 597-605. doi:10.1093/brain/118.3.597

[12]   C. J. Coe, “Guillain Barre Syndrome in Korean Children,” Yonsei Medical Journal, Vol. 30, No. 1, 1989, pp. 81-87.

[13]   S. V. Samad, R. M. Leila, H. Samaneh, D. Ghazaleh and H. Paria, “The Chronological Variation of Guillain Barre Syndrome (GBS) in North West of Iran,” Journal of Medical Sciences Research, Vol. 1, No. 3, 2011, pp. 19-24.

[14]   Z. Islam, B. C. Jacobs, M. B. Islam, Q. D. Mohammad, S. Diorditsa and H. P. Endtz, “High Incidence of GuillainBarré Syndrome in Children, Bangladesh,” Emerging Infectious Diseases, 2011. doi:10.3201/eid1707.101999

[15]   A. B. Haghighi, M. A. Banihashemi, N. Zamiri, B. Sabayan, S. T. Heydari and A. Safari, “Seasonal Variation of Guillain-Barré Syndrome Admission in a Large Tertiary Referral Center in Southern Iran: A 10 Year Analysis,” Acta Neurologica Taiwanica, Vol. 21, 2012, pp. 60-6321.

[16]   R. K. Lyu, L. M. Tang, S. Y. Cheng, W. C. Hsu and S. T. Chen, “Guillain-Barré Syndrome in Taiwan: A Clinical Study of 167 Patients,” Journal of Neurology, Neurosurgery & Psychiatry, Vol. 63, No. 4, 1997, pp. 494-500. doi:10.1136/jnnp.63.4.494

[17]   R. Van Koningsveld, R. Rico, I. Gerstenbluth, P. I. M. Schmitz, C. W. Ang and I. S. J. Merkies, “GastroenteritisAssociated Guillain-Barré Syndrome on the Caribbean Island Cura?ao,” Neurology, Vol. 56, No. 11, 2001, pp. 1467-1472. doi:10.1212/WNL.56.11.1467

[18]   K. Radhakrishnan, M. A. El-Mangoush and S. E. Gerryo, “Descriptive Epidemiology of Selected Neuromuscular Disorders in Benghazi, Libya,” Acta Neurologica Scandinavica, Vol. 75, No. 2, 1987, pp. 95-100. doi:10.1111/j.1600-0404.1987.tb07901.x

[19]   S. J. Winner and J. Grimley Evans, “Age-Specific Incidence of Guillain-Barré Syndrome in Oxfordshire,” Oxford Journals of Medicine, Vol. 77, No. 3, 1990, pp. 1297-1304. doi:10.1093/qjmed/77.3.1297

[20]   S. Congia, M. Melis and M. A. Carboni, “Epidemiologic and Clinical Features of the Guillain-Barre Syndrome in Sardinia in the 1961-1980 Period,” Acta Neurologica (Napoli), Vol. 11, No. 1, 1989, pp. 15-20.

[21]   J. P. Larson, G. Kvale and H. Nyland, “Epidemiology of the Guillain-Barre Syndrome in the County of Hordaland, Western Norway,” Acta Neurologica Scandinavica, Vol. 71, No. 1, 1985, pp. 43-47. doi:10.1111/j.1600-0404.1985.tb03165.x

[22]   V. Sivadon-Tardy, D. Orlikowski, F. Rozenberg, C. Caudie, T. Sharshar, P. Lebon, et al., “Guillain-Barré Syndrome, Greater Paris Area,” Emerging Infectious Diseases, Vol. 12, No. 6, 2006. doi:10.3201/eid1206.051369

[23]   M. Louie, J. M. Gilchrist and C. Woodland, “Guillain Barre Syndrome: A 5 Year Rhode Island Hospital Experience,” Rhode Island Medicine, Vol. 77, 1994, pp. 135-140.

[24]   M. A. Arami, M. Yazdchi and R. Khandaghi, “Epidemiology and Characteristics of Guillain Barre Syndrome in the Northwest of Iran,” Annals of Saudi Medicine, Vol. 26, No. 1, 2006, pp. 22-27.

[25]   E. Storey, M. Cook, R. Peppard, H. Newton-John and E. Byrne, “Guillain-Barre Syndrome and Related Conditions in Victorian Teaching Hospitals 1980-1984,” Australian and New Zealand Journal of Medicine, Vol. 19, No. 6, 1989, pp. 687-693. doi:10.1111/j.1445-5994.1989.tb00335.x

[26]   Z. Paolino, V. Govoni, M. R. Tola, I. Casetta and E. Granieri, “Incidence of the Guillain-Barre Syndrome in Ferrara, Northern Italy, 1981-1987,” Neuroepidemiology, Vol. 10, No. 3, 1991, pp. 105-111. doi:10.1159/000110254

[27]   V. Govoni, E. Granieri, M. R. Tola, I. Casetta, P. Ruppi and L. Vaghi, “The Frequency of Clinical Variants of Guillain-Barre Syndrome in Ferrara, Italy,” Journal of Neurology, Vol. 246, No. 11, 1999, pp. 1010-1014. doi:10.1007/s004150050505

[28]   M. J. Sedano, J. Calleja, E. Canga and J. Berciano, “Guillain-Barre Syndrome in Cantabria, Spain: An Epidemiological and Clinical Study,” Acta Neurologica Scandinavica, Vol. 89, No. 4, 1994, pp. 287-292. doi:10.1111/j.1600-0404.1994.tb01682.x

[29]   E. Dias-Tosta and C. S. Kuckelhaus, “Guillain Barré Syndrome in a Population Less than 15 Years Old in Brazil,” Arquivos de Neuro-Psiquiatria, Vol. 60, No. 2B, 2002, pp. 367-373. doi:10.1590/S0004-282X2002000300005

[30]   D. Rebecca Prevots and R. W. Sutter, “Assessment of Guillain-Barre Syndrome Mortality and Morbidity in the United States: Implications for Acute Flaccid Paralysis Surveillance,” The Journal of Infectious Diseases, Vol. 175, No. 1, 1997, pp. S151-S155 doi:10.1093/infdis/175.Supplement_1.S151

[31]   M. Y. Yakoob, A. Rahman, B. Jamil and N. A. Syed, “Characteristics of Patients with Guillain Barre Syndrome at a Tertiary Care Centre in Pakistan, 1995-2003,” Journal of the Pakistan Medical Association, Vol. 55, No. 11, 2005, pp. 493-496.

[32]   Q. Cheng, D. S. Wang, G. X. Jiang, H. Han, Y. Zhang, W. Z. Wang and S. Fredrikson, “Distinct Pattern of AgeSpecific Incidence of Guillain-Barré Syndrome in Harbin, China,” Journal of Neurology, Vol. 249, No. 1, 2002, pp. 25-32. doi:10.1007/PL00007844